You are here

Article info

Article menu

Download PDFPDF

Commentary
Letter to the editor from Pant et al

Authors

  • Shubham Pant Department of Investigational Cancer Therapeutics, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Justin T Moyers Department of Investigational Cancer Therapeutics, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USADivision of Hematology & Oncology, Department of Medicine, University of California Irvine, Orange, California, USA PubMed articlesGoogle scholar articles
  • Aung Naing Department of Investigational Cancer Therapeutics, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA PubMed articlesGoogle scholar articles

Citation

Pant S, Moyers JT, Naing A
Letter to the editor from Pant et al
Journal for ImmunoTherapy of Cancer 2021;9:e003991. doi: 10.1136/jitc-2021-003991
Online issue publication 
May 08, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.